Arañador, Jerry A.

HRN: 24-48-52  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2024
CEFTRIAXONE 1G (VIAL)
02/06/2024
02/13/2024
IV
2g
Q24
Fracture Close Completely M/3rd Radius R Sec To MVA
Waiting Final Action 
02/06/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/06/2024
02/13/2024
IV
600mg
Q8
Fracture Close Complete M/3rd Radius Right Sec To MVA
Waiting Final Action 
02/13/2024
CEFTRIAXONE 1G (VIAL)
02/13/2024
02/20/2024
IV
2g
Q24
MVA
Waiting Final Action 
02/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/13/2024
02/20/2024
IV
600mg
Q8
Mva
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: